Market Cap ₹8876 Cr.
Stock P/E 32.9
P/B 5.1
Current Price ₹719.3
Book Value ₹ 142
Face Value 2
52W High ₹838.2
Dividend Yield 0.42%
52W Low ₹ 510.3
Archean Chemical Industries Ltd is a chemical manufacturing company based in India. Established in 1992, the company produces a wide range of specialty chemicals used in various industries such as textiles, pharmaceuticals, agrochemicals, and more. Archean's product portfolio includes organic and inorganic chemicals, intermediates, and specialty chemicals. The company has a state-of-the-art manufacturing facility in the state of Gujarat, India, and employs over 500 people. Archean Chemical Industries is committed to delivering high-quality products and has received various certifications for its quality management systems. The company also focuses on sustainable development and has implemented measures to reduce its environmental impact. Archean's customer base includes leading domestic and international companies, and it has a strong presence in markets across Asia, Europe, and the Americas.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 |
---|---|
Net Sales | 250 |
Other Income | 8 |
Total Income | 257 |
Total Expenditure | 146 |
Operating Profit | 112 |
Interest | 42 |
Depreciation | 17 |
Exceptional Income / Expenses | 0 |
Profit Before Tax | 53 |
Provision for Tax | 14 |
Profit After Tax | 39 |
Adjustments | 0 |
Profit After Adjustments | 39 |
Adjusted Earnings Per Share | 0.8 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 225 | 341 | 288 | 439 | 566 | 608 | 741 | 1130 | 1441 | 1330 | 250 |
Other Income | 3 | 1 | 4 | 6 | 7 | 8 | 14 | 13 | 44 | 47 | 8 |
Total Income | 228 | 342 | 292 | 445 | 573 | 616 | 755 | 1143 | 1485 | 1376 | 257 |
Total Expenditure | 134 | 235 | 218 | 356 | 497 | 460 | 479 | 663 | 807 | 865 | 146 |
Operating Profit | 94 | 107 | 74 | 89 | 76 | 156 | 276 | 480 | 679 | 511 | 112 |
Interest | 51 | 106 | 106 | 102 | 114 | 122 | 130 | 162 | 97 | 10 | 42 |
Depreciation | 36 | 72 | 81 | 73 | 47 | 52 | 55 | 67 | 69 | 70 | 17 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 114 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 7 | -72 | -113 | -85 | 29 | -17 | 90 | 251 | 513 | 431 | 53 |
Provision for Tax | -53 | 14 | -40 | -6 | -12 | 18 | 24 | 63 | 129 | 109 | 14 |
Profit After Tax | 60 | -87 | -73 | -79 | 41 | -36 | 67 | 189 | 384 | 322 | 39 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 60 | -87 | -73 | -79 | 41 | -36 | 67 | 189 | 384 | 322 | 39 |
Adjusted Earnings Per Share | 12.1 | -17.3 | -14.6 | -15.8 | 4.3 | -3.7 | 6.9 | 19.6 | 31.2 | 26.1 | 0.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -8% | 22% | 19% | 0% |
Operating Profit CAGR | -25% | 23% | 46% | 0% |
PAT CAGR | -16% | 69% | 51% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 12% | NA% | NA% | NA% |
ROE Average | 21% | 59% | 40% | -60% |
ROCE Average | 28% | 39% | 31% | 18% |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 201 | 114 | 41 | -28 | 43 | 8 | 74 | 263 | 1433 | 1706 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 748 | 589 | 817 | 792 | 741 | 848 | 846 | 843 | 1 | 1 |
Other Non-Current Liabilities | -35 | 81 | 33 | 5 | 222 | 244 | 278 | 251 | 151 | 284 |
Total Current Liabilities | 463 | 553 | 346 | 409 | 141 | 254 | 182 | 176 | 192 | 124 |
Total Liabilities | 1376 | 1337 | 1237 | 1178 | 1147 | 1353 | 1381 | 1532 | 1777 | 2115 |
Fixed Assets | 772 | 1013 | 994 | 940 | 913 | 917 | 1042 | 1086 | 1097 | 1086 |
Other Non-Current Assets | 367 | 73 | 17 | 77 | 45 | 174 | 38 | 52 | 82 | 327 |
Total Current Assets | 237 | 251 | 226 | 161 | 189 | 262 | 301 | 394 | 597 | 702 |
Total Assets | 1376 | 1337 | 1237 | 1178 | 1147 | 1353 | 1381 | 1532 | 1777 | 2115 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 192 | 70 | 69 | 61 | 12 | 47 | 24 | 32 | 7 | 5 |
Cash Flow from Operating Activities | 117 | 270 | 118 | 39 | 312 | 148 | 119 | 327 | 498 | 389 |
Cash Flow from Investing Activities | -117 | -55 | 8 | 0 | -25 | -197 | -2 | -128 | -288 | -260 |
Cash Flow from Financing Activities | -122 | -216 | -133 | -87 | -252 | 26 | -110 | -224 | -212 | -91 |
Net Cash Inflow / Outflow | -122 | -1 | -8 | -48 | 35 | -23 | 7 | -24 | -2 | 39 |
Closing Cash & Cash Equivalent | 70 | 69 | 61 | 12 | 47 | 24 | 32 | 7 | 5 | 44 |
# | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 12.07 | -17.33 | -14.65 | -15.83 | 4.26 | -3.7 | 6.91 | 19.58 | 31.18 | 26.12 |
CEPS(Rs) | 19.2 | -2.85 | 1.62 | -1.28 | 9.17 | 1.69 | 12.66 | 26.52 | 36.75 | 31.8 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.5 | 3 |
Book NAV/Share(Rs) | 40.14 | 22.81 | 8.16 | -5.55 | 4.51 | 0.79 | 7.68 | 27.27 | 115.8 | 138.1 |
Core EBITDA Margin(%) | 40.25 | 30.24 | 23.59 | 18.75 | 12.16 | 24.34 | 35.4 | 41.34 | 44.02 | 34.92 |
EBIT Margin(%) | 25.7 | 9.81 | -2.41 | 3.66 | 25.26 | 17.17 | 29.82 | 36.54 | 42.33 | 33.17 |
Pre Tax Margin(%) | 3.12 | -20.73 | -38.1 | -19.33 | 5.16 | -2.85 | 12.21 | 22.24 | 35.6 | 32.44 |
PAT Margin (%) | 26.7 | -24.89 | -24.73 | -17.92 | 7.26 | -5.86 | 8.99 | 16.69 | 26.62 | 24.24 |
Cash Profit Margin (%) | 42.49 | -4.09 | 2.74 | -1.45 | 15.62 | 2.67 | 16.47 | 22.6 | 31.38 | 29.51 |
ROA(%) | 4.38 | -6.39 | -5.69 | -6.56 | 3.53 | -2.85 | 4.87 | 12.95 | 23.19 | 16.56 |
ROE(%) | 30.06 | -55.04 | -94.58 | -1210.43 | 523.94 | -139.72 | 163.22 | 112.05 | 45.47 | 20.6 |
ROCE(%) | 4.8 | 2.95 | -0.68 | 1.65 | 16.44 | 12.56 | 24.58 | 40.5 | 47.63 | 27.9 |
Receivable days | 39.69 | 36.71 | 44.37 | 21.92 | 30.16 | 33.45 | 27.72 | 35.69 | 34.28 | 37.55 |
Inventory Days | 159.1 | 111 | 147.92 | 98.94 | 56.57 | 48.48 | 51.6 | 37.36 | 36.54 | 40.46 |
Payable days | -226.72 | -1748.55 | 1243.28 | 931.83 | 465.76 | 0 | 5722.59 | 1040 | 0 | 407.77 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.87 | 25.65 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.62 | 4.85 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.38 | 0.45 |
EV/Net Sales(x) | 4.22 | 2.73 | 3.2 | 2.2 | 1.28 | 1.4 | 1.14 | 0.72 | 5.55 | 6.19 |
EV/Core EBITDA(x) | 10.13 | 8.73 | 12.41 | 10.86 | 9.57 | 5.45 | 3.06 | 1.69 | 11.78 | 16.1 |
Net Sales Growth(%) | 0 | 51.33 | -15.53 | 52.56 | 28.87 | 7.54 | 21.8 | 52.6 | 27.48 | -7.74 |
EBIT Growth(%) | 0 | -41.21 | -120.92 | 326.01 | 784.66 | -26.92 | 111.56 | 87.03 | 47.68 | -27.7 |
PAT Growth(%) | 0 | -243.6 | 15.45 | -8.07 | 151.87 | -186.82 | 286.76 | 183.26 | 103.41 | -15.98 |
EPS Growth(%) | 0 | -243.6 | 15.45 | -8.07 | 126.92 | -186.82 | 286.76 | 183.26 | 59.24 | -16.21 |
Debt/Equity(x) | 5.03 | 8.67 | 23.81 | -34.91 | 17.37 | 112.57 | 11.6 | 3.22 | 0.02 | 0 |
Current Ratio(x) | 0.51 | 0.45 | 0.65 | 0.39 | 1.34 | 1.03 | 1.65 | 2.24 | 3.11 | 5.66 |
Quick Ratio(x) | 0.3 | 0.25 | 0.29 | 0.12 | 0.9 | 0.64 | 1.04 | 1.56 | 2.23 | 4.64 |
Interest Cover(x) | 1.14 | 0.32 | -0.07 | 0.16 | 1.26 | 0.86 | 1.69 | 2.56 | 6.29 | 45.62 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|
Promoter | 53.6 | 53.6 | 53.6 | 53.6 | 53.45 | 53.45 | 53.45 |
FII | 6.03 | 5.47 | 4.06 | 2.92 | 4.15 | 5.86 | 9.53 |
DII | 29.79 | 30.26 | 30.78 | 30.39 | 28.69 | 27.14 | 21.04 |
Public | 10.57 | 10.67 | 11.55 | 13.09 | 13.71 | 13.54 | 15.97 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|
Promoter | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 |
FII | 0.74 | 0.67 | 0.5 | 0.36 | 0.51 | 0.72 | 1.18 |
DII | 3.67 | 3.72 | 3.79 | 3.74 | 3.54 | 3.35 | 2.6 |
Public | 1.3 | 1.31 | 1.42 | 1.61 | 1.69 | 1.67 | 1.97 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12.31 | 12.31 | 12.31 | 12.31 | 12.34 | 12.34 | 12.34 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About